January 4th, 2023 | 🕒
https://www.ispeech.org/text.to.speech DUBLIN--(BUSINESS WIRE)--The "Human Gene Sequencing Markets, Strategies & Trends - Forecasts by Application, by Technology, by Workflow, by Product,
January 3rd, 2023 | 🕒
iSpeech.org A new method can illuminate the identities and activities of cells throughout an organ or a tumor at unprecedented
December 20th, 2022 | 🕒
https://www.ispeech.org Bill Gates, who will become a grandfather early next year, weighs in on technologies being evaluated by the Bill
December 19th, 2022 | 🕒
TTS HUDSON FALLS, N.Y. — The Gene Haas Foundation recently awarded the local Employment Training for Adults (ETA) Machine Tool
December 15th, 2022 | 🕒
https://www.ispeech.org/text.to.speech Technology for modulating autoimmunity expands intellectual property portfolio AUSTIN, Texas , Dec. 15, 2022 /PRNewswire/ -- Genprex, Inc. ("Genprex" or the "Company")
December 13th, 2022 | 🕒
Text to Speech Demo CNN — For the first time, a new gene editing technology called base editing was used
November 14th, 2022 | 🕒
iSpeech Collaboration with a leader in gene editing systems is Ionis' latest move to expand and diversify its technology CRISPR-Cas
November 9th, 2022 | 🕒
iSpeech w2 is biased in males but not females. In the tCRISPR system, Cas9 is only active in males and,
October 11th, 2022 | 🕒
https://www.ispeech.org/text.to.speech ChristianaCare has spun out its first commercial biotechnology start-up, CorriXR Therapeutics with $5 million in seed funding CorriXR Therapeutics
October 10th, 2022 | 🕒
Text to Speech Under the microscope, researchers often observe different cell types organizing themselves in peculiar patterns within tissues, or
September 14th, 2022 | 🕒
iSpeech.org By combining traditional eye imaging techniques with adaptive optics - a technology that enhances imaging resolution - researchers at
September 2nd, 2022 | 🕒
Text to Speech SHENZHEN, China, Sept. 2, 2022 /PRNewswire/ -- With the step-by-step clarification of regulatory policies at home and
September 1st, 2022 | 🕒
iSpeech.org So far, B cells haven’t gotten the same attention—indeed, genetically engineered versions have never been tested in a human. That’s
August 25th, 2022 | 🕒
chinese tts An international team of scientists have demonstrated for the first time that CRISPR genome-editing technology can be used
Gloss